A new strategy to attack aggressive brain cancer shrank tumors in two early tests

by Lauran NeergaardThis combination of MRI scan images provided by theNew England Journal of Medicinein March 2024 shows the progress of a glioblastoma patient who received CAR-T therapy w

Updated on: March 20,2024

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

by Lauran NeergaardThis combination of MRI scan images provided by theNew England Journal of Medicinein March 2024 shows the progress of a glioblastoma patient who received CAR-T therapy w

Updated on:March 20,2024

Study reveals how diet and probiotics boost melanoma immunotherapy response

by University of PittsburghMarlies Meisel, Ph.D., assistant professor in the Department of Immunology at the University of Pittsburgh School of Medicine and member of the Cancer Immunology and Im

Updated on: February 23,2024

Study reveals how diet and probiotics boost melanoma immunotherapy response

by University of PittsburghMarlies Meisel, Ph.D., assistant professor in the Department of Immunology at the University of Pittsburgh School of Medicine and member of the Cancer Immunology and Im

Updated on:February 23,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on: May 20,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on:May 20,2024

Expert panel highlights patient choice for prostate cancer screen (Update)

by Dennis Thompson, Healthday ReporterMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0(HealthDay)—More men could receiv

Updated on: April 01,2024

Expert panel highlights patient choice for prostate cancer screen (Update)

by Dennis Thompson, Healthday ReporterMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0(HealthDay)—More men could receiv

Updated on:April 01,2024

Findings suggest common salt activates anti-tumor cells

by Friederike Gawlik, Leibniz Institute for Natural Product Research and Infection BiologyImmune cells (purple and blue) attack tumor cells (red). Highly active CD8⁺ T cells treated with sodium chlori

Updated on: September 10,2024

Findings suggest common salt activates anti-tumor cells

by Friederike Gawlik, Leibniz Institute for Natural Product Research and Infection BiologyImmune cells (purple and blue) attack tumor cells (red). Highly active CD8⁺ T cells treated with sodium chlori

Updated on:September 10,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on: January 16,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on:January 16,2024

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

Updated on: April 28,2024

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

Updated on:April 28,2024

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or

Updated on: April 01,2024

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or

Updated on:April 01,2024

CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e

Updated on: April 12,2024

CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e

Updated on:April 12,2024

New research may hold key to better treatments for aggressive brain cancer

by Spectrum HealthPrakash Chinnaiyan, M.D., a physician scientist in the Department of Radiation Oncology at Corewell Health in Southeast, Mich. Credit: Elizabeth Debeliso, Corewell HealthFor decades,

Updated on: January 13,2024

New research may hold key to better treatments for aggressive brain cancer

by Spectrum HealthPrakash Chinnaiyan, M.D., a physician scientist in the Department of Radiation Oncology at Corewell Health in Southeast, Mich. Credit: Elizabeth Debeliso, Corewell HealthFor decades,

Updated on:January 13,2024

First line immunotherapy combination fails to improve overall survival in lung cancer

by European Society for Medical OncologyStudy author Dr Naiyer Rizvi, director of thoracic oncology and immunotherapeutics, Columbia University Medical Center, New York, US. Credit: © European So

Updated on: May 23,2024

First line immunotherapy combination fails to improve overall survival in lung cancer

by European Society for Medical OncologyStudy author Dr Naiyer Rizvi, director of thoracic oncology and immunotherapeutics, Columbia University Medical Center, New York, US. Credit: © European So

Updated on:May 23,2024

US Preventive Services Task Force: Evidence still lacking for routine skin cancer screening

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is currently insufficient for assessing the balance of benefits and harms of screening asymptomatic adolescents and adults

Updated on: January 02,2024

US Preventive Services Task Force: Evidence still lacking for routine skin cancer screening

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is currently insufficient for assessing the balance of benefits and harms of screening asymptomatic adolescents and adults

Updated on:January 02,2024